Arcutis Biotherapeutics, Inc. (ARQT) Earnings
|
Expand Research on ARQT
| Next EPS Date | 7/30/26 | EPS Growth Rate | +130.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +43.2% | Revenue Growth Rate | +44.2% |
| Average % Move 1-Wk after EPS | -6.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | $0.04 | N/A | N/A | $117.54M | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | -$0.09 | -$0.05 | -$0.04 | $105.4M | $103.72M | N/A |  | | Details | |
| 2/25/26 | Q425 | $0.13 | $0.08 | +$0.05 | $129.5M | $111.14M | N/A | | | Details | |
| 10/28/25 | Q325 | $0.06 | -$0.09 | +$0.15 | $99.2M | $86.99M | N/A | | | Details | |
| 8/6/25 | Q225 | -$0.13 | -$0.17 | +$0.04 | $81.5M | $73.25M | N/A | | | Details | |
| 5/6/25 | Q125 | -$0.20 | -$0.21 | +$0.01 | $65.8M | $63.66M | N/A | | | Details | |
| 2/25/25 | Q424 | -$0.09 | -$0.28 | +$0.19 | $71.3M | $54.72M | N/A | | | Details | |
| 11/6/24 | Q324 | -$0.33 | -$0.42 | +$0.09 | $44.75M | $37.62M | N/A | | | Details |
